BioAtla

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.

About BCAB

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. 

CEO
Jay M. Short
CEOJay M. Short
Employees
56
Employees56
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
56
Employees56

BCAB Key Statistics

Market cap
302.37M
Market cap302.37M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
554.39K
Average volume554.39K
High today
$9.06
High today$9.06
Low today
$7.84
Low today$7.84
Open price
$8.24
Open price$8.24
Volume
757.18K
Volume757.18K
52 Week high
$32.76
52 Week high$32.76
52 Week low
$2.01
52 Week low$2.01

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

BCAB Earnings

-$1.50
-$0.79
-$0.07
$0.64
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.